Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A glassware-free combinatorial synthesis of green quantum dots using bubble wrap.

RSC advances·2022

Same author

MRI-Guided Focused Ultrasound as a New Method of Drug Delivery.

Journal of drug delivery·2013

Same author

Biosynthesis of luminescent quantum dots in an earthworm.

Nature nanotechnology·2012

Same author

A rare case of postpartum thrombocytosis. Differential diagnosis and management.

Il Giornale di chirurgia·2012

Same author

Biodegradation, biodistribution and toxicity of chitosan.

Advanced drug delivery reviews·2009

Same author

Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.

International journal of pharmaceutics·2008

Search research articles

Related Experiment Video

Updated: Jun 14, 2026

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Targeting nanoparticles to cancer.

M Wang¹, M Thanou

¹Imperial College London, Department of Chemistry, United Kingdom.

Pharmacological Research

|April 13, 2010

Summary

This summary is machine-generated.

Nanomedicine uses nanoparticles for cancer therapy and diagnosis. Optimizing nanoparticle circulation and tumor delivery is crucial for improving cancer treatment efficacy.

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

In Vivo Targeting of Xenografted Human Cancer Cells with Functionalized Fluorescent Silica Nanoparticles in Zebrafish

In Vivo Targeting of Xenografted Human Cancer Cells with Functionalized Fluorescent Silica Nanoparticles in Zebrafish

Published on: May 8, 2020

Related Experiment Videos

Last Updated: Jun 14, 2026

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

In Vivo Targeting of Xenografted Human Cancer Cells with Functionalized Fluorescent Silica Nanoparticles in Zebrafish

In Vivo Targeting of Xenografted Human Cancer Cells with Functionalized Fluorescent Silica Nanoparticles in Zebrafish

Published on: May 8, 2020

Area of Science:

Nanomedicine
Biotechnology
Materials Science

Background:

Nanotechnology enables the development of nanoparticles for targeted cancer imaging and treatment.
Nanoparticles offer advantages in drug delivery, including passive targeting via the enhanced permeation and retention effect.
Challenges remain in achieving efficient cell uptake and intracellular drug release, despite strategies like PEGylation and ligand decoration.

Purpose of the Study:

To review the current state of nanoparticles in cancer therapy and diagnosis.
To highlight the role of passive and active targeting strategies in nanomedicine.
To identify areas for optimization in nanoparticle design and application for improved cancer treatment.

Main Methods:

Review of existing literature on nanoparticle applications in oncology.
Analysis of nanoparticle characteristics, including size, chemistry, and surface modifications (e.g., PEGylation, ligand conjugation).
Evaluation of targeting mechanisms, such as the enhanced permeation and retention effect and receptor-mediated endocytosis.

Main Results:

Nanoparticles can be engineered for both diagnostic and therapeutic purposes (theranostic nanoparticles).
Passive targeting relies on the enhanced permeation and retention effect for tumor accumulation.
Active targeting using ligands enhances cellular uptake through receptor-mediated endocytosis.
Various materials like polymers, liposomes, and inorganic nanoparticles are employed in nanomedicine for cancer.
Despite progress, optimizing nanoparticle circulation time and tumor bioavailability requires further research.

Conclusions:

Nanoparticles show significant promise in cancer theranostics, with many advancing to clinical trials.
Further development of novel ligands and conjugation chemistry is essential for enhancing nanoparticle efficiency.
Improving nanoparticle kinetics, including plasma circulation and tumor bioavailability, is key to maximizing therapeutic outcomes.